Delivery Order SPE2DB22D9239-SPE2DB23FDG46
Award Date 2/5/23
Potential Completion Date 2/27/23
Potential Value $144K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency has awarded a Firm Fixed Price Delivery Order to DMS Pharmaceutical Group Inc., a Woman-Owned Small Business, to provide 300 mg vials of the pharmaceutical drug Entyvio. The contract has a potential value of $144,367.80 and a completion date of March 9, 2023. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand name and generic prescription and over-the-counter drug supplies to the federal government, primarily...
- The Defense Logistics Agency awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the pharmaceutical product Entyvio. The contract has a potential value of $226,837.92 and a completion date of September 28, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles (IDVs) with the Defense Logistics Agency to supply a variety of...
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Entyvio 300 mg vials. The $39,429.44 award has a completion date of January 30, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts to supply pharmaceuticals and medical products to the Department of Defense. This delivery order is issued against DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the pharmaceutical product Entyvio. The potential value of this contract is $59,144.16, with a period of performance through January 25, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that supports the Department of Defense by supplying a range of brand-name and generic...
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the pharmaceutical product Entyvio. The award has a potential value of $141,773.70 and a completion date of September 16, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles to supply a wide range of pharmaceutical and medical products to support...
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business. The $144,367.80 contract is for the supply of Entyvio 300 mg vials, a pharmaceutical product, with a completion date of March 24, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drugs to the federal government, primarily the Department of Defense,...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the pharmaceutical product Entyvio. The order has a potential value of $111,200.16 and a completion date of December 30, 2021. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles to supply a variety of pharmaceutical and medical...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the pharmaceutical drug Entyvio. The order has a completion date of October 13, 2021 and a potential value of $199,233.62. DMS Pharmaceutical Group holds multiple contracts and indefinite delivery vehicles with the Defense Logistics Agency to supply a wide range of pharmaceutical and medical products to support...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $48,122.70 by the Defense Logistics Agency to provide 4562986926 units of Entyvio 300 mg vials. The delivery order was awarded on November 30, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. As a woman-owned small business and pharmaceutical...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the pharmaceutical drug Entyvio. The delivery order has a potential value of $113,685.84 and a completion date of April 5, 2022. DMS Pharmaceutical Group holds a broader indefinite delivery contract with the Defense Logistics Agency to supply a variety of pharmaceutical and medical products to support military...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB23FDG46Delivery Order
The Defense Logistics Agency awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 milligram vials of the pharmaceutical drug Entyvio. The firm fixed price contract has a potential value of $144,367.80 and a completion date of February 27, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds a variety of federal contracts to supply pharmaceuticals and medical products to the Department of Defense and military treatment facilities worldwide.
Generated 3/23/24, 4:21 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $144.4k | 2/5/23 |